LLY

Eli Lilly & Co.

897.45

USD

LLY Earnings Reports

Positive Surprise Ratio

LLY beat 28 of 40 last estimates.

70%

Next Report

Date of Next Report

Apr 30, 2026

Estimate for Q1 26 (Revenue/ EPS)

$17.64B

$7.32

Implied change from Q4 25 (Revenue/ EPS)

-8.57%

-2.92%

Implied change from Q1 25 (Revenue/ EPS)

+38.58%

+119.16%

Eli Lilly & Co. earnings per share and revenue

On Feb 04, 2026, LLY reported earnings of 7.54 USD per share (EPS) for Q4 25, beating the estimate of 6.73 USD, resulting in a 11.92% surprise. Revenue reached 19.29 billion, compared to an expected 18.14 billion, with a 6.36% difference. The market reacted with a +10.33% price change (close before vs. close after earnings).

Looking ahead to Q1 26, 12 analysts forecast an EPS of 7.32 USD, with revenue projected to reach 17.64 billion USD, implying an decrease of -2.92% EPS, and decrease of -8.57% in Revenue from the last quarter.

FAQ

What were Eli Lilly & Co.'s earnings and revenue for the latest quarter Q4 2025?

For Q4 2025, Eli Lilly & Co. reported EPS of $7.54, beating estimates by 11.92%, and revenue of $19.29B, 6.36% above expectations.

How did the market react to Eli Lilly & Co.'s Q4 2025 earnings?

The stock price moved up 10.33%, changed from $1.00K before the earnings release to $1.11K the day after.

When is Eli Lilly & Co. expected to report next?

The next earning report is scheduled for Apr 30, 2026.

What are the forecasts for Eli Lilly & Co.'s next earnings report?

Based on 12 analysts, Eli Lilly & Co. is expected to report EPS of $7.32 and revenue of $17.64B for Q1 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.